Breast Screening clinical trials at University of California Health
1 research study open to eligible people
open to eligible females ages 45-74
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Our lead scientists for Breast Screening research studies include Rita I. Freimanis.